Search - tctmd.com

Displaying 201 - 220 of 343

Sort: Relevancy | Date

Presentation TCT 2016

Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together?

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Robert W. Yeh

October 31, 2016

Presentation TCT 2016

Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses

October 31, 2016

Presentation TCT 2016

Primary PCI in Patients With Multivessel Disease: Overview of Randomized Trials and Unanswered Questions

Presenter: Ran Kornowski, Michel R. Le May, Kevin Bainey

October 31, 2016

Presentation TCT 2016

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

Presenter: Sorin J. Brener, Jean-François Tanguay, Rafael Cavalcante

October 31, 2016

Presentation TCT 2016

Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BEST to SYNTAX II and Beyond

Presenter: Dean J. Kereiakes, Pieter C. Smits, Patrick W. Serruys

October 30, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR in Multivessel Disease: FAME-1 and Substudies

Presenter: Nico H. J. Pijls

October 28, 2016

Presentation

Long-term Mortality After Revascularization in Nondiabetic Patients With Multivessel Disease

Presenter: Mineok Chang

June 28, 2016

Presentation

Second- vs First-Generation DES in Multivessel Disease With Left Main Stenosis

Presenter: Carlos Haiek

March 14, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

IVUS and FFR in Left Main and Multivessel Disease

Presenter: Jeffrey W. Moses

March 10, 2016

Presentation

Complete Revascularization Confers Clinical Benefit in High-Risk Patients With Multivessel Disease

Presenter: Marco Zimarino

January 20, 2016

Presentation

Revascularization in Diabetics With Multivessel Disease: Population-Based Evaluation of Outcomes

Presenter: Krishnan Ramanathan

November 16, 2015

Presentation TCT 2015

BRS in Multivessel Disease

Presenter: David W.M. Muller, Ashok Seth, Robert-Jan van Geuns

October 15, 2015

Presentation TCT 2015

Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials

Presenter: Frederick Feit, David J. Maron, Michael E. Farkouh

October 15, 2015

Presentation TCT 2015

New Approaches for Diffuse Disease: DEB, BRS, and Beyond

Presenter: Jeffrey W. Moses, Erick Schampaert, Giuseppe Tarantini

October 14, 2015

Presentation TCT 2015

SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead?

Presenter: Jeffrey W. Moses, Erick Schampaert, Dimitri Karmpaliotis

October 14, 2015

Presentation TCT 2015

Debate: Should Atheroablation Be Used More Often? Yes, Atheroablation Is Underutilized!

Presenter: Jeffrey W. Moses, Erick Schampaert, Nabil Dib

October 14, 2015

Presentation TCT 2015

Debate: Should Atheroablation Be Used More Often? No, the Present Evidence Says It Should Be Used Sparingly!

Presenter: Jeffrey W. Moses, Erick Schampaert, Gert Richardt

October 14, 2015

Presentation TCT 2015

Atheroablation: Current Technologies and Techniques

Presenter: Jeffrey W. Moses, Erick Schampaert, Mohamed Abdel-Wahab

October 14, 2015

Presentation TCT 2015

CTO in Patients With Left Main and Multivessel Disease: Why and When to Treat

Presenter: Jeffrey W. Moses, Erick Schampaert, Barry D. Rutherford

October 14, 2015

Presentation TCT 2015

Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach

Presenter: Jeffrey W. Moses, Erick Schampaert

October 14, 2015

Advertisement

Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together?

Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go

Primary PCI in Patients With Multivessel Disease: Overview of Randomized Trials and Unanswered Questions

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BEST to SYNTAX II and Beyond

FFR in Multivessel Disease: FAME-1 and Substudies

Long-term Mortality After Revascularization in Nondiabetic Patients With Multivessel Disease

Second- vs First-Generation DES in Multivessel Disease With Left Main Stenosis

IVUS and FFR in Left Main and Multivessel Disease

Complete Revascularization Confers Clinical Benefit in High-Risk Patients With Multivessel Disease

Revascularization in Diabetics With Multivessel Disease: Population-Based Evaluation of Outcomes

BRS in Multivessel Disease

Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials

New Approaches for Diffuse Disease: DEB, BRS, and Beyond

SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead?

Debate: Should Atheroablation Be Used More Often? Yes, Atheroablation Is Underutilized!

Debate: Should Atheroablation Be Used More Often? No, the Present Evidence Says It Should Be Used Sparingly!

Atheroablation: Current Technologies and Techniques

CTO in Patients With Left Main and Multivessel Disease: Why and When to Treat

Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content